Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Plasminogen activator inhibitor (PAI-1) in plasma and platelets.

Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR.

Br J Haematol. 1988 Nov;70(3):327-33.

PMID:
3264718
2.

The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease.

Simpson AJ, Booth NA, Moore NR, Bennett B.

Br J Haematol. 1990 Aug;75(4):543-8.

PMID:
2207005
3.

Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D.

Blood. 1988 Jan;71(1):220-5.

5.

The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma.

Serizawa K, Urano T, Kozima Y, Takada Y, Takada A.

Thromb Res. 1993 Aug 15;71(4):289-300.

PMID:
8236158
6.

Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women.

Häggroth L, Mattsson C, Felding P, Nilsson IM.

Thromb Res. 1986 Jun 1;42(5):585-94.

PMID:
3087015
7.

Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women.

Nilsson IM, Felding P, Lecander I, Lennér C, Astedt B.

Br J Haematol. 1986 Feb;62(2):215-20.

PMID:
3484963
8.

Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.

Kawasaki T, Dewerchin M, Lijnen HR, Vermylen J, Hoylaerts MF.

Blood. 2000 Jul 1;96(1):153-60.

9.

Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.

Kahr WH, Zheng S, Sheth PM, Pai M, Cowie A, Bouchard M, Podor TJ, Rivard GE, Hayward CP.

Blood. 2001 Jul 15;98(2):257-65.

10.

Fibrinolytic imbalance in essential thrombocythemia: role of platelets.

Bazzan M, Tamponi G, Gallo E, Stella S, Schinco PC, Pannocchia A, Pileri A.

Haemostasis. 1993;23(1):38-44.

PMID:
8477907
11.

Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.

Soeki T, Tamura Y, Fukuda N, Ito S.

Jpn Circ J. 2000 Aug;64(8):547-53.

12.

Acetylsalicylic acid inhibits platelet PAI-1 antigen release without affecting circulating PAI-1 antigen in plasma.

Cogo A, Ling E, Sturk A, ten Cate JW, Prandoni P.

Ric Clin Lab. 1990 Apr-Jun;20(2):113-7.

PMID:
2371491
13.

Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples.

Leng HM, Brouwers E, Knockaert I, Declerck PJ.

Thromb Haemost. 2000 Dec;84(6):1082-6.

PMID:
11154117
14.

[Study on fibrinolysis and platelet function].

Deguchi K, Murashima S, Nishikawa M, Shirakawa S.

Nihon Rinsho. 1992 Feb;50(2):297-302. Japanese.

PMID:
1613983
15.

The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.

Robbie LA, Booth NA, Croll AM, Bennett B.

Thromb Haemost. 1993 Aug 2;70(2):301-6.

PMID:
8236139
16.

Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.

Torr-Brown SR, Sobel BE.

Thromb Res. 1993 Dec 1;72(5):413-21.

PMID:
8303684
17.

Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.

Fay WP, Eitzman DT, Shapiro AD, Madison EL, Ginsburg D.

Blood. 1994 Jan 15;83(2):351-6.

18.

Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.

Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.

Med Sci Monit. 2000 Jul-Aug;6(4):684-91.

19.

Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).

Milton JG, Frojmovic MM, Tang SS, White JG.

Am J Pathol. 1984 Feb;114(2):336-45.

20.

Supplemental Content

Support Center